The relationship of the neo-angiogenic marker, endoglin, with response to neoadjuvant chemotherapy in breast cancer
Mark Beresford(Royal United Hospital Bath NHS Trust), Andreas Makris(Institute of Cancer Research)
Cited by 47
Related Papers
Adjuvant chemotherapy in older women (ACTION) study – what did we learn from the pilot phase?
|British Journal of Cancer|2011|50